Tag: AbbVie
Moore Kuehn, PLLC Encourages Investors of AbbVie Inc. or International Business...
NEW YORK, April 13, 2022 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential...
Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) F… –...
Company Announcement
Based on the topline results from the EPCORE™ NHL-1 clinical trial, Genmab and AbbVie will engage global regulatory authorities to discuss next...
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages AbbVie Inc. Investors With Losses …...
NEW YORK, April 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing...
Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing...
Alvotech expects AVT02 (adalimumab) will...